2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
16
Plasma cell
14
Other hematologic neoplasm
7
Classical hematology
6
Myeloid
3
Thoracic
2
Sarcoma
1
Other solid neoplasm
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Breast
1
Conditions
Colorectal Neoplasms
5945
Pancreatic Neoplasms
3561
Carcinoma, Hepatocellular
3271
Stomach Neoplasms
3056
Colonic Neoplasms
2327
Rectal Neoplasms
2191
Esophageal Neoplasms
1800
Liver Neoplasms
1246
Neoplasms
1181
Breast Neoplasms
1064
Neoplasm Metastasis
870
Carcinoma, Non-Small-Cell Lung
792
Lung Neoplasms
744
Cholangiocarcinoma
743
Gastrointestinal Neoplasms
662
Ovarian Neoplasms
630
Esophageal Squamous Cell Carcinoma
584
Prostatic Neoplasms
485
Melanoma
457
Biliary Tract Neoplasms
441
Head and Neck Neoplasms
376
Uterine Cervical Neoplasms
344
Carcinoma, Renal Cell
329
Gastrointestinal Stromal Tumors
326
Adenocarcinoma Of Esophagus
315
Sarcoma
303
Barrett Esophagus
300
Anus Neoplasms
284
Gallbladder Neoplasms
283
Endometrial Neoplasms
281
Interventions
Tinzaparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hemostatic Disorders
×
Gastrointestinal
×
Clear all
NCT03099031
2019-12-16
PREDICARE
LEO Pharma
Completed
420 enrolled